Nutra Pharma Corp Stock Number Of Employees
| NPHC Stock | USD 0.0001 0.00 0.00% |
Nutra Pharma Corp fundamentals help investors to digest information that contributes to Nutra Pharma's financial success or failures. It also enables traders to predict the movement of Nutra Pink Sheet. The fundamental analysis module provides a way to measure Nutra Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutra Pharma pink sheet.
Nutra |
Nutra Pharma Corp Company Number Of Employees Analysis
Nutra Pharma's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Nutra Pharma Number Of Employees | 4 |
Most of Nutra Pharma's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutra Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Nutra Pharma Corp is currently employing 4.0 people. This is 99.96% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of employees for all United States stocks is 99.98% higher than that of the company.
Nutra Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutra Pharma's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutra Pharma could also be used in its relative valuation, which is a method of valuing Nutra Pharma by comparing valuation metrics of similar companies.Nutra Pharma is currently under evaluation in number of employees category among related companies.
Nutra Fundamentals
| Return On Asset | -1.13 | |||
| Profit Margin | 28.71 % | |||
| Operating Margin | (5.58) % | |||
| Current Valuation | 10.33 M | |||
| Shares Outstanding | 7.6 B | |||
| Shares Owned By Insiders | 1.02 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Sales | 6.13 X | |||
| Revenue | 51.9 K | |||
| Gross Profit | 8.47 K | |||
| EBITDA | (365.66 K) | |||
| Net Income | (769.18 K) | |||
| Cash And Equivalents | 10.45 K | |||
| Total Debt | 517.18 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (878.09 K) | |||
| Target Price | 0.53 | |||
| Beta | 0.25 | |||
| Market Capitalization | 759.68 K | |||
| Total Asset | 301.79 K | |||
| Z Score | -2.7 | |||
| Net Asset | 301.79 K |
About Nutra Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nutra Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nutra Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nutra Pharma's short interest history, or implied volatility extrapolated from Nutra Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutra Pharma Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Nutra Pharma Corp information on this page should be used as a complementary analysis to other Nutra Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |